This 190-page “Artificial Intelligence for Drug Discovery Landscape Overview, Q1 2022” report marks another instalment in a series of reports on the topic of the Artificial Intelligence (AI) application in the pharmaceutical research industry that DPI has been producing since 2017.

The main aim of this series of reports is to provide a comprehensive overview of the industry landscape regarding the adoption of AI in drug discovery, clinical research and other aspects of pharmaceutical R&D. This overview highlights trends and insights in the form of informative mind maps and infographics, and benchmarks the performance of key players that form the space and relations within the industry. This is an overview analysis to help the reader understand what is happening in the industry currently and possibly give an idea of what is coming next.

Alongside investment and business trends, the report also provides technical insights into some of the latest achievements in AI application and research.